copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
European Society for Medical Oncology ESMO Courses in Medical Oncology for Medical Students ESMO Scale for Clinical Actionability of molecular Targets (ESCAT) ESMO Guidance for Reporting Oncology real-World Evidence (ESMO-GROW) COVID-19 and Cancer: Registries, Studies and Surveys ESMO Designated Centres of Integrated Oncology and Palliative Care
2023 ESMO Palliative Care Fellowship Report Aarathi Ardha To empower all the palliative care team members to deliver appropriate patient care, especially in a cancer centre with a high patient load Protocol development for screening patients with supportive and palliative care needs and triaging them for effective management
Supportive Care for Cancer Patients Remains Inadequate Supportive care such as pain relief, antibiotics and drugs to prevent nausea is recommended for advanced cancer patients undergoing chemotherapy by ESMO (1,2) and the World Health Organization (3), among others
Medical Oncology Unit of San Paolo Hospital Carlo Chenis Hospic - ESMO Specialities Within the Oncology Unit we take care of patients affected by any kind of solid tumors Supportive and Palliative Care is delivered in every stage of patient disease in order to offer the best possible cancer care
Latest European Commission Initiative on Breast Cancer - ESMO The European Breast Guidelines provide women and healthcare providers with clear, objective and independent guidance on breast cancer screening and diagnosis They guide healthcare managers and policy-makers in planning, organising and monitoring the effectiveness of services for breast cancer screening and diagnosis
Archive - ESMO On 11 December, 2015 the US Food and Drug Administration (FDA) approved uridine triacetate (Vistogard) for the emergency treatment of adults and children who receive an overdose of the cancer treatment fluorouracil or capecitabine, or who develop certain severe or life-threatening toxicities within four days of receiving these cancer treatments “Treating cancer requires not only selecting
Prostate Cancer | ESMO Palliative and Supportive Care Sessions at ESMO Congress 2022 Paris Palliative and Supportive Care Sessions at ESMO Congress 2023 Madrid Palliative and Supportive Care Sessions at ESMO Congress 2024 Barcelona Traitement du Cancer au Cours de la Pandémie de COVID-19 Le Cure per il Cancro Durante la Pandemia da COVID-19
News - ESMO References 1 Abstract 496O_PR - ‘Health-related quality of life and psychological distress among cancer survivors in a middle-income Asian country,’ will be presented by Shridevi Subramaniam during Proffered Paper Session: Supportive and palliative care on Sunday 18th December at 09:45 (SGT)
Tamar Esakia - Palliative Care Fellowship Report Goals of the Project: The objective of applying for the Palliative care fellowship, for me as for medical oncologist, was to understand the basic formation in supportive and palliative care in order to improve and integrate management for advanced cancer patients
Crizotinib in c-MET- or ROS1-positive Non-Small Cell Lung Cancer The AcSé phase II study points out to crizotinib activity in patients with ROS1 -translocated non-small cell lung cancer (NSCLC) In case of c-MET-mutation and c-MET ≥6 copies cohorts, despite insufficient overall response rate (ORR), there are signs of late response, but not sufficient to justify further research of crizotinib in this indication The study results are published by Prof